Abstract #LBA100

ミスマッチ修復機構欠損を有する腫瘍におけるPembrolizumab療法の第II相試験

PD-1 Blockade in Tumors with Mismatch Repair Deficiency

Dung Le, et al.

Abstract #3504

切除不能大腸癌における2次予防*としてのアスピリンの影響：25,644例によるpopulation based study

Impact of Aspirin as Secondary Prevention in an Unselected Cohort of 25,644 Patients with Colorectal Cancer: A Population-based Study

Simer Bains, et al.

Abstract #3507

FOLFOX ± Cetuximabによる術後補助化学療法を受けたマイクロサテライト安定性 (MSS) stage III大腸癌のBRAF V600EとKRAS exon 2変異型の予後に与える影響: PETACC8試験、N0147試験の3,934例のプール解析

Prognostic Value of BRAF V600E and KRAS exon 2 Mutations in Microstatellite Stable, Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX ± Cetuximab: A Pooled Analysis of 3934 Patients from the PETACC8 and N0147 Trials

Julien Taieb, et al.

Abstract #3508

HER2陽性切除不能進行・再発大腸癌患者に対するTrastuzumabとLapatinibの併用療法：HERACLES trial

Trastuzumab and Lapatinib in HER2-amplified Metastatic Colorectal Cancer Patients (mCRC): The HERACLES Trial

Salvatore Siena, et al.